ArticleResearch (Washington, D.C.)2025

Isovalerylspiramycin I Reprograms the Immunosuppressive and Temozolomide-Resistant Microenvironment by Inhibiting the Frizzled-5/Wnt/β-Catenin Pathway in Glioblastoma.

Xin Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.